(Q40528036)

21 September 2017

Experimental squalene adjuvant. II. Harmlessness and local reactogenity (English)

1 reference

21 September 2017

Zdenek Benísek

1

1 reference

21 September 2017

Judit Süli

2

1 reference

21 September 2017

Daniel Eliás

3

1 reference

21 September 2017

L'udovít Lenhardt

4

1 reference

21 September 2017

Anna Ondrejková

5

1 reference

21 September 2017

Róbert Ondrejka

6

1 reference

21 September 2017

Stefan Svrcek

7

1 reference

21 September 2017

Viera Bajová

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

21 September 2017

1 reference

21 September 2017

22

1 reference

21 September 2017

25-26

1 reference

21 September 2017

3470-3474

1 reference

A comparison of commercially available adjuvants for use in research

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Effect of DETOX as an adjuvant for melanoma vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Design and selection of vaccine adjuvants: animal models and human trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Evaluation of pluronic polyols as carriers for grafting materials: study in rat calvaria defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Experimental squalene adjuvant. I. Preparation and testing of its effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

The global impact of vaccines containing aluminium adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Postvaccinal sarcomas in the cat: histology and immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982-1993).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Aluminum salts in vaccines--US perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Investigation of the hydrocarbons found in the tissues of chickens injected with inactivated oil adjuvant vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

Squalene and squalane emulsions as adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.024

10.1016/J.VACCINE.2004.02.024

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference